Here are relevant reports on : needle-roller-bearing-market
-
Hydrogen Valve Market by Type (Ball, Needle, Check, Pressure Relief, Globe, Flow Control), Size, Material (Steel, Aluminum), Pressure, Implementation, Application (Production, Fueling Station, Storage, Transportation, Fuel Sell) - Global Forecast to 2030
The global hydrogen valve market is expected to grow from USD 331 million in 2024 to USD 507 million by 2030, at a compound annual growth rate (CAGR) of 7.4% during the forecast period.The key players Emerson Electric Co. (US), IMI (UK), SLB (US), Valmet (Finland), Crane Company (US), Westport Fuel Systems Inc. (Canada), KITZ Corporation (US), PARKER HANNIFIN CORP (US), Baker Hughes Company (US).
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The North America Cell Culture Market, valued at US$11.10 billion in 2024, stood at US$11.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$20.38 billion by the end of the period. Growth of the North America cell culture market is driven by a strong and expanding biopharmaceutical industry, with rising production of biologics such as monoclonal antibodies, vaccines, and cell-based therapies that rely heavily on advanced culture techniques and systems.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Plastic Surgery Instruments Market by Type (Handheld (Forceps, Needle Holder, Scissors, Retractor), Electrosurgery (Bipolar, Monopolar)), Procedure (Cosmetic (Breast Augmentation, Face, Head, Extremities), Reconstructive), End User - Global Forecast to 2023
The global plastic surgery instruments market is projected to reach USD 1,479.0 Million by 2023, growing at a CAGR of 8.1%. Prominent players in the plastic surgery instruments market include Sklar Surgical Instruments (US), KLS Martin Group (Germany), Integra LifeSciences Corporation (US), Tekno-Medical Optik-Chirurgie GmbH (Germany), KARL STORZ GmbH & Co. KG (Germany), Zimmer Biomet (US), B. Braun Melsungen AG (Germany), BMT Medizintechnik GmbH (Germany), Anthony Products, Inc. (US), Bolton Surgical Ltd. (UK), Surgicon Pvt. Ltd. (Pakistan), and Blink Medical (UK).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031
The Middle East & Africa injectable drug delivery market, valued at US$15.46 billion in 2025, stood at US$16.46 billion in 2026 and is projected to advance at a resilient CAGR of 6.5% from 2026 to 2031, culminating in a forecasted valuation of US$22.54 billion by the end of the period. The demand for fill-and-finish services is increasing, contributing to the growth of the injectable drug delivery market in the Middle East & Africa.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Microsurgical Instruments Market by Type (Operating Microscopes, Micro Sutures (Non-Absorbable & Absorbable), Forceps, Needle Holder), Microsurgery (Plastic, Ophthal, ENT, Orthopedic, GYN), End User (Hospitals, ASCs, Academia) - Global Forecast to 2024
The Microsurgical Instruments Market is expected to grow from USD 1.7 billion in 2019 to USD 2.2 billion by 2024, at a CAGR of 1.7% during the forecast period. B. Braun Melsungen AG (Germany), ZEISS International (Germany), Danaher Corporation (US), Olympus Corporation (Japan), Novartis AG (Switzerland), Karl Kaps GmbH & Co. KG (Germany), Scanlan International (US), Topcon Corporation (Japan), Global Surgical Corporation (US), Haag-Streit Surgical (Germany), Accurate Surgical & Scientific Instruments (US), and Stille (Sweden) are some of the key players in the microsurgical instruments market.
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Tension Control Market by Type (Automated & Manual), Component (Load Cell, Controller, Diameter Sensor, Dancer Roller, Brake, Clutch), Application (Paper, Flexible Printing & Packaging, Metal & Foil, Others), and Region - Global Forecast to 2022
The global tension control market is estimated to be USD 891.4 Million in 2017 and is projected to reach USD 1,118.8 Million by 2022, growing at a CAGR of 4.65%, from 2017 to 2022. The increasing demand for automated tension control and the rising transition toward flexible printing & packaging from rigid packaging are driving the tension control market globally. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the tension control market. These include Maxcess (US), Montalvo (US), Erhardt+Leimer (Germany), FMS (Switzerland), Double E (US), Nireco (Japan), and Re (Italy). The leading players are trying to understand the markets in developing economies and are adopting various strategies to increase their market shares.
- Published: April 2018
- Price: $ 4950
- TOC Available:
-
Asia Pacific Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Asia Pacific cell culture Market, valued at US$6.49 billion in 2024, stood at US$6.98 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$12.40 billion by the end of the period. Biopharma companies in the region are expanding the production of monoclonal antibodies, vaccines, biosimilars, and recombinant proteins based on cell culture in the Asia Pacific cell culture market, which is thus growing.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Conveyor System Market By Industry (Retail & Distribution, Food & Beverage, Automotive, Electronic, Mining, & Airport), Type (Belt, Roller, Overhead, Floor, Pallet, Crescent, Cable, Bucket) Component, Operation & Region - Global Forecast to 2030
The global conveyor system market is projected to reach USD 14.81 billion by 2030, registering a CAGR of 6.0% during the forecast period. The Conveyor System market is dominated by global players such as Siemens AG (Germany), Continental AG (Germany), Daifuku Co., Ltd. (Japan), Fives Group (Paris), and Taikisha Ltd (Japan) among others. These companies adopted new product development strategies, expansion, partnerships & collaborations, and mergers & acquisitions to gain traction in the market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Europe Cell Culture Market, valued at US$8.01 billion in 2024, stood at US$8.50 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.23 billion by the end of the period. The growth of the Europe cell culture market is driven by a strong and expanding biopharmaceutical sector, with rising production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins that rely on sophisticated culture systems.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
